167 related articles for article (PubMed ID: 19266905)
1. The neuroprotective effects of progesterone on experimental diabetic neuropathy in rats.
Sameni HR; Panahi M; Sarkaki A; Saki GH; Makvandi M
Pak J Biol Sci; 2008 Aug; 11(16):1994-2000. PubMed ID: 19266905
[TBL] [Abstract][Full Text] [Related]
2. Anti-allodynic and neuroprotective effects of koumine, a Benth alkaloid, in a rat model of diabetic neuropathy.
Ling Q; Liu M; Wu MX; Xu Y; Yang J; Huang HH; Yu CX
Biol Pharm Bull; 2014; 37(5):858-64. PubMed ID: 24790009
[TBL] [Abstract][Full Text] [Related]
3. The Effect of Co-administration of 4-Methylcatechol and Progesterone on Sciatic Nerve Function and Neurohistological Alterations in Streptozotocin-Induced Diabetic Neuropathy in Rats.
Sameni H; Panahi M
Cell J; 2011; 13(1):31-8. PubMed ID: 23671825
[TBL] [Abstract][Full Text] [Related]
4. Gliclazide inhibits diabetic neuropathy irrespective of blood glucose levels in streptozotocin-induced diabetic rats.
Qiang X; Satoh J; Sagara M; Fukuzawa M; Masuda T; Miyaguchi S; Takahashi K; Toyota T
Metabolism; 1998 Aug; 47(8):977-81. PubMed ID: 9711995
[TBL] [Abstract][Full Text] [Related]
5. Jinmaitong ameliorates diabetes-induced peripheral neuropathy in rats through Wnt/β-catenin signaling pathway.
Song W; Sun Y; Liang XC; Zhang Q; Xie J; Wang C; Liu W
J Ethnopharmacol; 2021 Feb; 266():113461. PubMed ID: 33039625
[TBL] [Abstract][Full Text] [Related]
6. Histopathological study of evening primrose oil effects on experimental diabetic neuropathy.
Omran OM
Ultrastruct Pathol; 2012 Aug; 36(4):222-7. PubMed ID: 22574767
[TBL] [Abstract][Full Text] [Related]
7. Progesterone and its derivatives are neuroprotective agents in experimental diabetic neuropathy: a multimodal analysis.
Leonelli E; Bianchi R; Cavaletti G; Caruso D; Crippa D; Garcia-Segura LM; Lauria G; Magnaghi V; Roglio I; Melcangi RC
Neuroscience; 2007 Feb; 144(4):1293-304. PubMed ID: 17187935
[TBL] [Abstract][Full Text] [Related]
8. Streptozotocin induced diabetes as a model of phrenic nerve neuropathy in rats.
Rodrigues Filho OA; Fazan VP
J Neurosci Methods; 2006 Mar; 151(2):131-8. PubMed ID: 16125783
[TBL] [Abstract][Full Text] [Related]
9. The therapeutic effects of 4-methylcatechol, a stimulator of endogenous nerve growth factor synthesis, on experimental diabetic neuropathy in rats.
Hanaoka Y; Ohi T; Furukawa S; Furukawa Y; Hayashi K; Matsukura S
J Neurol Sci; 1994 Mar; 122(1):28-32. PubMed ID: 8195800
[TBL] [Abstract][Full Text] [Related]
10. The influence of sulindac on experimental streptozotocin-induced diabetic neuropathy.
Zochodne DW; Ho LT
Can J Neurol Sci; 1994 Aug; 21(3):194-202. PubMed ID: 8000974
[TBL] [Abstract][Full Text] [Related]
11. Effects of a new aldose reductase inhibitor, (2S, 4S)-6-fluoro-2',5'-dioxospiro[chroman-4,4'-imidazolidine]-2-ca rboxamid e (SNK-860), on the slowing of motor nerve conduction velocity and metabolic abnormalities in the peripheral nerve in acute streptozotocin-induced diabetic rats.
Mizuno K; Kato N; Matsubara A; Nakano K; Kurono M
Metabolism; 1992 Oct; 41(10):1081-6. PubMed ID: 1328819
[TBL] [Abstract][Full Text] [Related]
12. Taurine protects against myelin damage of sciatic nerve in diabetic peripheral neuropathy rats by controlling apoptosis of schwann cells via NGF/Akt/GSK3β pathway.
Li K; Shi X; Luo M; Inam-U-Llah ; Wu P; Zhang M; Zhang C; Li Q; Wang Y; Piao F
Exp Cell Res; 2019 Oct; 383(2):111557. PubMed ID: 31415759
[TBL] [Abstract][Full Text] [Related]
13. Tanshinone IIA improves impaired nerve functions in experimental diabetic rats.
Liu Y; Wang L; Li X; Lv C; Feng D; Luo Z
Biochem Biophys Res Commun; 2010 Aug; 399(1):49-54. PubMed ID: 20637731
[TBL] [Abstract][Full Text] [Related]
14. Evaluation of orally active poly(ADP-ribose) polymerase inhibitor in streptozotocin-diabetic rat model of early peripheral neuropathy.
Li F; Szabó C; Pacher P; Southan GJ; Abatan OI; Charniauskaya T; Stevens MJ; Obrosova IG
Diabetologia; 2004 Apr; 47(4):710-7. PubMed ID: 15298348
[TBL] [Abstract][Full Text] [Related]
15. Escin alleviates peripheral neuropathy in streptozotocin induced diabetes in rats.
Suryavanshi SV; Kulkarni YA
Life Sci; 2020 Aug; 254():117777. PubMed ID: 32407839
[TBL] [Abstract][Full Text] [Related]
16. Neuroprotective effects of octreotide on diabetic neuropathy in rats.
Solmaz V; Çınar BP; Yiğittürk G; Özlece HK; Avni Eroglu H; Tekatas A; Erbaş O; Taşkıran D
Biomed Pharmacother; 2017 May; 89():468-472. PubMed ID: 28249248
[TBL] [Abstract][Full Text] [Related]
17. ACE inhibitor or angiotensin II receptor antagonist attenuates diabetic neuropathy in streptozotocin-induced diabetic rats.
Coppey LJ; Davidson EP; Rinehart TW; Gellett JS; Oltman CL; Lund DD; Yorek MA
Diabetes; 2006 Feb; 55(2):341-8. PubMed ID: 16443766
[TBL] [Abstract][Full Text] [Related]
18. Zinc supplementation alleviates diabetic peripheral neuropathy by inhibiting oxidative stress and upregulating metallothionein in peripheral nerves of diabetic rats.
Liu F; Ma F; Kong G; Wu K; Deng Z; Wang H
Biol Trace Elem Res; 2014 May; 158(2):211-8. PubMed ID: 24615552
[TBL] [Abstract][Full Text] [Related]
19. GLP‑1R agonists ameliorate peripheral nerve dysfunction and inflammation via p38 MAPK/NF‑κB signaling pathways in streptozotocin‑induced diabetic rats.
Ma J; Shi M; Zhang X; Liu X; Chen J; Zhang R; Wang X; Zhang H
Int J Mol Med; 2018 May; 41(5):2977-2985. PubMed ID: 29484377
[TBL] [Abstract][Full Text] [Related]
20. Effects of adenosine and adenosine A2A receptor agonist on motor nerve conduction velocity and nerve blood flow in experimental diabetic neuropathy.
Kumar S; Arun KH; Kaul CL; Sharma SS
Neurol Res; 2005 Jan; 27(1):60-6. PubMed ID: 15829161
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
